<html>
<head>
  <title>SARS-CoV-2 Spike protein (S) gene T470N;E471V;I472P literature reference collection</title>
  <link rel="stylesheet" href="constellations.css">
</head>
<body>
<h1><a href="front.html">SARS-CoV-2</a> <a href="S.html">Spike protein (S)</a> gene <span class="constellation">S:p.T470N;E471V;I472P</span> literature reference collection</h1>
<div class="effect_section"><h2 id="antibody_epitope_effects">Antibody epitope effects</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> This mutation prevents neutralization by COVA2-29 (cluster I), COVA2-07 (cluster III) and COVA2-02 (cluster  VII).<br/>It also reduces the activity of the most potent mAb COVA1-18 (cluster I) by 3-fold, whereas this  mAb is only minimally affected by other mutations. Moreover, TEI470-2NVP lowers the potency  of the structurally unmapped non-RBD cluster XI mAb,  COVA1-21, to the limit of detection.<br/>Thus, this mutation negatively impacts the most mAbs, including representatives from four  separate epitope clusters.<br/> (<a href="https://doi.org/10.1101/2021.01.15.426849" class="lit_link">Rees-Spear et al. (2021)</a>)</span></li>
</ul></div>
<div class="acknowledgement">Automatically generated using text2ui script and data from <a href="https://github.com/nodrogluap/pokay">Pokay</a></div>
</body>
</html>
